[{"id": 1199173, "guidelineid": 100421, "drugid": "RxNorm:190521", "implications": {"HLA-B": "Significantly increased risk of abacavir hypersensitivity"}, "drugrecommendation": "Abacavir is not recommended", "classification": "Strong", "phenotypes": {}, "activityscore": {}, "allelestatus": {"HLA-B": "HLA-B*57:01 positive"}, "lookupkey": {"HLA-B": "*57:01 positive"}, "population": "general", "comments": "n/a", "version": 1, "drug": {"name": "abacavir"}, "guideline": {"name": "HLA-B and Abacavir"}}, {"id": 1199172, "guidelineid": 100421, "drugid": "RxNorm:190521", "implications": {"HLA-B": "Low or reduced risk of abacavir hypersensitivity"}, "drugrecommendation": "Use abacavir per standard dosing guidelines", "classification": "Strong", "phenotypes": {}, "activityscore": {}, "allelestatus": {"HLA-B": "HLA-B*57:01 negative"}, "lookupkey": {"HLA-B": "*57:01 negative"}, "population": "general", "comments": "n/a", "version": 1, "drug": {"name": "abacavir"}, "guideline": {"name": "HLA-B and Abacavir"}}]